Measurement of distress in Chinese inpatients with lymphoma

Authors

  • Yisi Wang,

    1. Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
    Search for more papers by this author
    • Yisi Wang and Liqun Zou contributed equally to this work.
  • Liqun Zou,

    1. Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
    Search for more papers by this author
  • Ming Jiang,

    1. Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
    Search for more papers by this author
  • Yuquan Wei,

    1. Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
    Search for more papers by this author
  • Yu Jiang

    Corresponding author
    • Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China
    Search for more papers by this author
    • Yisi Wang and Liqun Zou contributed equally to this work.

Correspondence to: Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. E-mail: jiangyu1973@hotmail.com

Abstract

Purpose

The aim of this study was to assess the levels and sources of distress in patients with lymphoma. This study also focused on the influence of factors of the level of distress and the cutoff score using the Distress Thermometer (DT) relative to the Hospital Anxiety and Depression Scale (HADS).

Method

DT and HADS were used to estimate the psychological status of 323 eligible lymphoma patients. The DT was evaluated against the HADS for its sensitivity and specificity.

Results

One hundred and ninety-three (59.7%) lymphoma patients experienced overall distress on the HADS, with 137 (42.4%) experiencing anxiety and 114 (35.3%) suffering from depression. There were 199 (61.6%) and 163 (50.5%) patients with distress score ≥4 and ≥5, respectively. DT was significantly correlated with the HADS-total (T) (r = 0.820, p < 0.001), HADS-depression (D) (r = 0.763, p < 0.001), and HADS-anxiety (A) (r = 0.738, p < 0.001). The consistency of the DT and HADS was favorable (coherence index = 0.6030, p < 0.01) when the cutoff score was 5 for the DT. Referring to the cutoff of 15 on HADS, 5 on DT yielded optimal specificity (0.869, p < 0.001) and sensitivity (0.756, p < 0.001). In multiple logistic regression analysis, patients with ‘B symptoms’ were more likely to have a distress score ≥5 [OR = 4.512, p < 0.05, 95% CI 1.953–10.467].

Conclusion

DT is efficacious for screening for anxiety and depression in lymphoma patients. Copyright © 2012 John Wiley & Sons, Ltd.

Ancillary